(Palo Alto, CA – November 1, 2013) – Galileo Analytics Co-Founder Anna McCollister-Slipp will speak at the upcoming DiabetesMine Innovation Summit at the Stanford Medical School on November 16.
McCollister-Slipp will speak about the need for patients to lead the way to drive innovation in a range of important areas, such as medical device innovation, data integration, device interoperability and usability, all of which will help improve our ability to understand and manage chronic illnesses, such as diabetes.
In its third year, the annual DiabeteMine Innovation Summit brings together a range of top-level stakeholders in the diabetes community to focus attention on the need for speeding the rate of innovation in medical devices.
In addition to McCollister-Slipp, the summit will feature speakers from the FDA, West Health Institute and TidePool, a new non-profit formed by diabetes parents and patients, which develops patient-focused diabetes data applications. Afternoon panels will feature executives from Aetna, Capital Blue Cross/Blue Shield, Humana and Kaiser Permanente discussing the role of payers and insurers in promoting innovation in diabetes devices and care.
For further information about the DiabetesMine Innovation Summit and to see the full agenda, click here.
